» Articles » PMID: 14758095

Relevance of Breast Cancer Cell Lines As Models for Breast Tumours: an Update

Overview
Specialty Oncology
Date 2004 Feb 6
PMID 14758095
Citations 318
Authors
Affiliations
Soon will be listed here.
Abstract

The number of available breast cancer cell (BCC) lines is small, and only a very few of them have been extensively studied. Whether they are representative of the tumours from which they originated remains a matter of debate. Whether their diversity mirrors the well-known inter-tumoural heterogeneity is another essential question. While numerous similarities have long been found between cell lines and tumours, recent technical advances, including the use of micro-arrays and comparative genetic analysis, have brought new data to the discussion. This paper presents most of the BCC lines that have been described in some detail to date. It evaluates the accuracy of the few of them widely used (MCF-7, T-47D, BT-474, SK-BR-3, MDA-MB-231, Hs578T) as tumour models. It is concluded that BCC lines are likely to reflect, to a large extent, the features of cancer cells in vivo. The importance of oestrogen receptor-alpha (gene ESR1 ) and Her-2/ neu ( ERBB2 ) as classifiers for cell lines and tumours is underlined. The recourse to a larger set of cell lines is suggested since the exact origin of some of the widely used lines remains ambiguous. Investigations on additional specific lines are expected to improve our knowledge of BCC and of the dialogue that these maintain with their surrounding normal cells in vivo.

Citing Articles

Development of a phenotypic screening assay to measure activation of cancer-associated fibroblasts.

Ilg M, Lapthorn A, Harding S, Minhas T, Koduri G, Bustin S Front Pharmacol. 2025; 16:1526495.

PMID: 40017592 PMC: 11865240. DOI: 10.3389/fphar.2025.1526495.


Expression and clinical significance of CCN5 and the oestrogen receptor in advanced breast cancer.

Zhou G, Qu W, Yang L, Huang A, Gui X BMC Womens Health. 2025; 25(1):89.

PMID: 40016720 PMC: 11866700. DOI: 10.1186/s12905-025-03608-3.


A reappraisal of cell cycle phase enrichment in synchronized estrogen receptor-positive cell models derived from breast adenocarcinomas.

Toker P, Ayten H, Demiralay O, Binarci B, Turan G, Olgun C Sci Rep. 2025; 15(1):5949.

PMID: 39966575 PMC: 11836305. DOI: 10.1038/s41598-025-90456-8.


Metabolic Profiling of Breast Cancer Cell Lines: Unique and Shared Metabolites.

Gallo M, Ferrari E, Brugnoli F, Terrazzan A, Ancona P, Volinia S Int J Mol Sci. 2025; 26(3).

PMID: 39940737 PMC: 11816582. DOI: 10.3390/ijms26030969.


Imaging of cellular dynamics from a whole organism to subcellular scale with self-driving, multiscale microscopy.

Daetwyler S, Mazloom-Farsibaf H, Zhou F, Segal D, Sapoznik E, Chen B Nat Methods. 2025; 22(3):569-578.

PMID: 39939720 DOI: 10.1038/s41592-025-02598-2.